comprehensive -WSS

comprehensive

author：hotspot 2025-08-24 04:07:43 - browse：6

In 2018, New York University became the first U.S. medical school to go tuition free. Since then, a handful of others have followed with many more considering similar programs. One hope for free tuition endeavors is that lower post-graduation debt will increase the number of med students who choose lower-paying, desperately needed careers in primary care and pediatrics. But free tuition programs are not necessarily delivering on that promise.

In this episode of the First Opinion Podcast, University of Pennsylvania oncologist and researcher Ezekiel Emanuel and Matthew Guido, a project manager in the Healthcare Transformation Institute, discuss their original research on tuition-free programs with former host Pat Skerrett, who is filling in while Torie Bosch is on maternity leave. They make the case that medical school debt is only one of many factors that influence new doctors to choose less-popular specialties and geographic locations for their residencies. Other factors including prestige, the lifetime earning potential of higher-pay specialties, which can add several millions dollars over a career, can have more sway than student debt alone. This is especially important, they say, as needs for patients with chronic illnesses are rapidly outpacing the number of primary care physicians available to give that care.

“We have undervalued both philosophically and also financially the complications of managing chronic illness,” Emanuel says. “Can we rebalance the payment system that rewards the improvements in health and therefore the attention to chronic illness through primary care?”

You can read more about Emanuel and Guido’s opinions in their essay “Free med school tuition won’t solve the shortage of primary care physicians.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： Psychedelics group wrestles with new pharma identity
Next article： A disappointing year of Humira biosimilars

WSS

Sage considers ways to reduce costs following FDA rejection

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Restaurant meals are packed with calories, and we still keep eating them

Biogen Alzheimer’s drug launch off to slow start

Trump used to be more articulate. What could explain the change?

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

knowledge

comprehensive

hotspot

Supreme Court strikes down use of affirmative action

'Brian's Song' at 50 still offers lessons about cancer for today

Trump demands the U.S. pay no more for drugs than other countries … again

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

Continuity nursing helped my family in our darkest PICU moments

The Readout: Gilead, Bernie Sanders, and other pharma news

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Readout LOUD podcast: How biotech is using artificial intelligence

Sports medicine is finally prioritizing gender equality

How CRISPR works, explained in two minutes

focus

Severe weather updates: 1 million customers without power in 11 states as storms pummel East Coast

Kansas bar where gunfire wounded 9 last month closes permanently

Google's generative AI to analyze medical images — and talk to docs

Medicare Advantage proposed rates disappoint insurers

Flash flood warnings continue for parts of Missouri, Illinois

Severe weather updates: 1 million customers without power in 11 states as storms pummel East Coast

knowledge

hotspot

focus

Wikipedia